Company registration number 08501773 (England and Wales)
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 9
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
5
10,589,856
10,580,000
Current assets
Debtors
6
214,626
239,770
Cash at bank and in hand
108,069
357,483
322,695
597,253
Creditors: amounts falling due within one year
7
(5,044,840)
(5,866,549)
Net current liabilities
(4,722,145)
(5,269,296)
Total assets less current liabilities
5,867,711
5,310,704
Provisions for liabilities
(1,416,159)
(1,396,170)
Net assets
4,451,552
3,914,534
Capital and reserves
Called up share capital
2
2
Revaluation reserve
9
3,544,031
3,544,031
Profit and loss reserves
907,519
370,501
Total equity
4,451,552
3,914,534
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 25 September 2025 and are signed on its behalf by:
S. C. Patel
Director
Company registration number 08501773 (England and Wales)
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information
Westgate Healthcare (Braintree) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 3 Devonshire Business Park, Chester Road, Borehamwood, Hertfordshire, WD6 1NA.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties at fair value. The principal accounting policies adopted are set out below.
1.2
Going concern
The financial statements have been prepared on a going concern basis notwithstanding the excess of truecurrent liabilities over current assets. Because of the forbearance of the company's creditors and their willingness to support the company, the directors are confident that the company will be able to continue trading for the foreseeable future.
1.3
Turnover
Turnover represents the amounts due in exchange for services rendered and is recognised as earned when, and to the extent, that the company obtains the right to consideration in exchange for its performance. It is derived entirely from the company’s principle activities that are exempt for VAT purposes.
Turnover reflects the accrual of the right to consideration by reference to the value of the services rendered. Turnover not billed is included in debtors, and amounts received on account in excess of the relevant amount of revenue are included in creditors.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is provided at rates calculated to write off the cost or valuation less estimated residual value of each asset over its expected useful life, from the date the assets are brought into use.
Freehold land buildings
Nil
Fixtures, fittings & equipment
15% reducing balance
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Freehold property is held in the accounts under the revaluation model. Revaluations will be made with sufficient regularity to ensure that the carrying amount does not differ materially from that which would be determined using fair value at the end of the reporting period.
No depreciation is provided on the company’s freehold buildings. Given the length of life of the buildings and because they are maintained to high standards, it is the opinion of the directors that the residual value would be sufficiently high to make any depreciation charge immaterial.
The land and buildings have been valued on an open value basis at 31 December 2024 by the directors but with reference to independent professional valuations undertaken in connection with the company’s financing facilities.
The surplus or deficit on book value is transferred to the revaluation reserve, except that a deficit which is in excess of any previously recognised surplus over depreciated cost relating to the same property, or the reversal of such a deficit, is charged (or credited) to the profit and loss account. A deficit which represents a clear consumption of economic benefits is charged to the profit and loss account regardless of any such previous surplus.
On disposal or recognition of a provision for impairment of a revalued fixed asset any related balance remaining in the revaluation reserve is also transferred to the profit and loss account as a movement on reserves.
1.5
Impairment of fixed assets
At each reporting end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Cash and cash equivalents
Cash and cash equivalents include cash in hand and deposits held at call with banks.
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.7
Financial instruments
A financial instrument is a contract that gives rise to a financial asset of one entity and a financial liability of another entity.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.13
All borrowing costs, including interest incurred on loans used to finance construction projects, are recognised in the profit and loss over the term of the borrowings.
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
2
Judgements and key sources of estimation uncertainty
The directors make estimates and assumptions concerning the future. The resulting accounting estimate will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below.
The company carries its freehold land and property under the revaluation model. The land and buildings have been valued on an open value basis at 31 December 2024 by the directors but with reference to independent professional valuations undertaken in connection with the company’s financing facilities. The valuer used a valuation technique based on a fair maintainable trade value which is the sustainable income and costs multiplied by a factor and using assumptions of the demographic of the area and local competitors. There is a degree of estimation involved in that each property is unique and the value can only ultimately be reliably tested in the market itself.
3
Employees
The average monthly number of persons (excluding directors) employed by the company during the year was:
2024
2023
Number
Number
Operational and managerial staff
52
47
4
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
5,727
Deferred tax
Origination and reversal of timing differences
120,132
171,853
Total tax charge
125,859
171,853
In addition to the amount charged to the profit and loss account, the following amounts relating to tax have been recognised directly in other comprehensive income:
2024
2023
£
£
Deferred tax arising on:
Revaluation of property
-
344,000
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost or valuation
At 1 January 2024
10,538,331
84,000
10,622,331
Additions
17,029
17,029
At 31 December 2024
10,538,331
101,029
10,639,360
Depreciation and impairment
At 1 January 2024
42,331
42,331
Depreciation charged in the year
7,173
7,173
At 31 December 2024
49,504
49,504
Carrying amount
At 31 December 2024
10,538,331
51,525
10,589,856
At 31 December 2023
10,538,331
41,669
10,580,000
The land and buildings have been valued on an open value basis at 31 December 2024 by the directors but with reference to independent professional valuations undertaken in connection with the company’s financing facilities.
The freehold land and buildings have been pledged to secure borrowings of the company. See note 7.
At 31 December 2024, had the revalued assets been carried at historic cost less accumulated depreciation and accumulated impairment losses, their carrying amount would have been as follows:
2024
2023
£
£
Cost
5,863,442
5,863,442
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
92,846
57,427
Amounts owed by group undertakings
20,470
Other debtors
101,310
82,200
214,626
139,627
Deferred tax asset
100,143
214,626
239,770
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
7
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
1,811,250
1,932,000
Trade creditors
380,871
376,622
Amounts owed to group undertakings
2,721,893
Corporation tax
5,727
Other taxation and social security
35,311
32,839
Other creditors
89,788
3,525,088
5,044,840
5,866,549
The bank loan from Clydesdale Bank PLC is secured by fixed and floating charges over the company's assets including its freehold land and property. Interest is payable on the loan at 2.5% per annum above LIBOR. Repayment of the bank loan commenced on 31 December 2019.
The loan is repayable by quarterly instalments and was due to be repaid by 25 January 2025. Subsequent to the year end, the loan was extended and is now due to be repaid by 13 June 2030.
8
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Balances:
£
£
£
£
Accelerated capital allowances
285,300
265,311
-
-
Tax losses
-
-
-
100,143
Revaluations of tangible fixed assets
1,130,859
1,130,859
-
-
1,416,159
1,396,170
100,143
2024
Movements in the year:
£
Liability at 1 January 2024
1,296,027
Charge to profit or loss
120,132
Liability at 31 December 2024
1,416,159
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so.
The expected net reversal of deferred tax assets and liabilities in 2025 cannot be reliably estimated.
There is no expiry date on timing differences.
WESTGATE HEALTHCARE (BRAINTREE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
9
Revaluation reserve
2024
2023
£
£
At the beginning of the year
3,544,031
2,512,028
Revaluation surplus arising in the year
1,376,003
Deferred tax on revaluation of tangible assets
-
(344,000)
At the end of the year
3,544,031
3,544,031
10
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:
The auditor's report was unqualified.
Senior Statutory Auditor:
Stephen Simou FCA
Statutory Auditor:
TC Group
Date of audit report:
30 September 2025
11
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2024
2023
£
£
Fixtures and fittings
15,949
25,798
12
Related party transactions
At the year end the company owed a director £nil (2023: £840,000). The loan was unsecured, interest free, and repayable on demand.
At the year end, the company owed a net amount of £nil (2023: £2,421,769) to companies over which the directors have significant influence. These amounts were unsecured, interest free, and repayable on demand.
The company has taken advantage of the exemption in FRS 102 Section 33 - Related Party Disclosures, from the requirement to disclose transactions with wholly owned group companies.
13
Parent company
The parent company is Westgate Healthcare Group Limited ('WHGL'), a company registered in England and Wales.
Consolidated financial statements are prepared by WHGL, copies of which are available from its registered office: Unit 3 Devonshire Business Park, Chester Road, Borehamwood, Hertfordshire, WD6 1NA.
2024-12-312024-01-01falsefalsefalse30 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityP. S. PatelA. P. PatelS. C. PatelS. P. FoxonT. D. Teubner085017732024-01-012024-12-31085017732024-12-31085017732023-12-3108501773core:LandBuildings2024-12-3108501773core:OtherPropertyPlantEquipment2024-12-3108501773core:LandBuildings2023-12-3108501773core:OtherPropertyPlantEquipment2023-12-3108501773core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3108501773core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3108501773core:CurrentFinancialInstruments2024-12-3108501773core:CurrentFinancialInstruments2023-12-3108501773core:ShareCapital2024-12-3108501773core:ShareCapital2023-12-3108501773core:RevaluationReserve2024-12-3108501773core:RevaluationReserve2023-12-3108501773core:RetainedEarningsAccumulatedLosses2024-12-3108501773core:RetainedEarningsAccumulatedLosses2023-12-3108501773core:RevaluationReserve2023-12-3108501773core:RevaluationReserve2022-12-3108501773bus:Director32024-01-012024-12-3108501773core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3108501773core:FurnitureFittings2024-01-012024-12-31085017732023-01-012023-12-3108501773core:UKTax2024-01-012024-12-3108501773core:UKTax2023-01-012023-12-3108501773core:LandBuildings2023-12-3108501773core:OtherPropertyPlantEquipment2023-12-31085017732023-12-3108501773core:LandBuildings2024-01-012024-12-3108501773core:OtherPropertyPlantEquipment2024-01-012024-12-3108501773core:WithinOneYear2024-12-3108501773core:WithinOneYear2023-12-3108501773core:RevaluationReserve2024-01-012024-12-3108501773bus:PrivateLimitedCompanyLtd2024-01-012024-12-3108501773bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3108501773bus:FRS1022024-01-012024-12-3108501773bus:Audited2024-01-012024-12-3108501773bus:Director12024-01-012024-12-3108501773bus:Director22024-01-012024-12-3108501773bus:Director42024-01-012024-12-3108501773bus:Director52024-01-012024-12-3108501773bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP